Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pooja Mehra, M.D.

Concepts (25)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Pooja Mehra's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Pooja Mehra has written about over time.
Antineoplastic Combined Chemotherapy Protocols, 1 publications between 2018 and 2018, average publication date December 2018. Cyclophosphamide, 1 publications between 2018 and 2018, average publication date December 2018. Disease-Free Survival, 1 publications between 2018 and 2018, average publication date December 2018. Doxorubicin, 1 publications between 2018 and 2018, average publication date December 2018. Lymphoma, Follicular, 1 publications between 2018 and 2018, average publication date December 2018. Prednisone, 1 publications between 2018 and 2018, average publication date December 2018. Vincristine, 1 publications between 2018 and 2018, average publication date December 2018. Carcinoma, Renal Cell, 1 publications between 2020 and 2020, average publication date October 2020. Clinical Trials, Phase I as Topic, 1 publications between 2020 and 2020, average publication date October 2020. Dose-Response Relationship, Drug, 1 publications between 2020 and 2020, average publication date October 2020. Neoplasms, 1 publications between 2020 and 2020, average publication date October 2020. Research Design, 1 publications between 2020 and 2020, average publication date October 2020.

To see the data from this visualization as text, click here.
Mehra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.